Gilead Sciences Inc. (GILD) Share Price ($):47.37 Price Change: -0.37 (-0.78%)

Expand Company Information
Volume 10,887,436 Avg Volume 9,805,173
Day's Low $46.52 Day's High $47.45
52-wk Low $22.66 52-wk High $49.48
Previous Close $47.74 Open Price $46.90
Dividend $NA Yield NA%
Market Cap 72,191,400,000 P/E (Forward) 23.69
Chart for GILD
Exchange: NASDAQ Industry: Pharmaceuticals & Biotechnology Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes: What's This?
    Find a Broker »
    Choose Option: 

    Income Statement (Non-Cumulative)

    Print Current View
      Fiscal Q4
    Ending 12/12    		 Fiscal Q3
    Ending 09/12    		 Fiscal Q2
    Ending 06/12    		 Fiscal Q1
    Ending 03/12    		 Fiscal Q4
    Ending 12/11
    Sales/Revenue
    		 2,564,972 2,387,388 2,390,127 2,271,222 2,223,937
    Cost of Goods Sold (COGS) incl. D&A
    		 675,818 597,269 617,345 580,931 584,447
    COGS excluding D&A
    		 602,187 526,273 549,933 514,764 511,022
    Depreciation & Amortization Expense
    		 73,631 70,996 67,412 66,167 73,425
    Gross Income
    		 1,889,154 1,790,119 1,772,782 1,690,291 1,639,490
    SG&A Expense
    		 805,484 785,414 728,749 901,332 715,155
    Research & Development
    		 439,659 465,831 396,244 458,211 375,636
    Other SG&A
    		 365,825 319,583 332,505 443,121 339,519
    Other Operating Expense
    		 0 0 0 0 0
    Unusual Expense
    		 12,231 -5,548 -105,107 19,159 1,366
    Non Operating Income/Expense
    		 36,930 30,156 -91,123 -3,699 -29,128
    Equity in Affiliates (Pretax)
    		 NA 0 0 0 0
    Interest Expense
    		 85,906 89,322 88,418 97,270 74,998
    Gross Interest Expense
    		 85,906 89,322 88,418 97,270 74,998
    Pretax Income
    		 1,022,463 951,087 969,599 668,831 818,843
    Income Tax
    		 263,504 280,052 263,525 231,300 157,084
    Equity in Affiliates
    		 0 0 0 0 0
    Consolidated Net Income
    		 758,959 671,035 706,074 437,531 661,759
    Minority Interest Expense
    		 -3,582 -4,470 -5,490 -4,425 -3,386
    Net Income
    		 762,541 675,505 711,564 441,956 665,145
    Extraordinaries & Discontinued Operations
    		 0 0 0 0 0
    Extra Items & Gain/Loss Sale Of Assets
    		 0 0 0 0 0
    Cumulative Effect - Accounting Chg
    		 0 0 0 0 0
    Discontinued Operations
    		 0 0 NA 0 0
    Net Income After Extraordinaries
    		 762,540 675,505 711,564 441,956 665,145
    Preferred Dividends
    		 0 0 0 0 0
    Net Income available to Common
    		 762,541 675,505 711,564 441,956 665,145
    Operational EPS
    		 0.49 0.42 0.41 0.29 0.42
    EPS (basic)
    		 0.50 0.45 0.47 0.29 0.43
    EBITDA
    		 1,157,301 1,075,701 1,111,445 855,126 997,760
    Depreciation & Amortization Expense
    		 73,631 70,996 67,412 66,167 73,425
    Common Shares Outstanding
    		 1,582,549 1,584,608 1,561,012 1,554,776 1,580,236
    Basic Shares Outstanding
    		 1,514,621 1,514,770 1,513,902 1,512,572 1,549,806
    Diluted Shares Outstanding
    		 1,582,549 1,584,608 1,561,012 1,554,776 1,580,236
    Diluted EPS after Extraordinary Items
    		 0.48 0.43 0.46 0.28 0.42
    Discont. Operations Per Share
    		 0 0 0 0 0
    Continued operations EPS
    		 0.50 0.45 0.47 0.29 0.42
    *Figures in thousands of U.S. Dollars except shares outstanding.
    • Print Snapshot
    • Stock Compare
    • Receive Stock Alerts
    • Receive News Alerts
    • Glossary
    • RSS
    • Price Check Calculator
    • Annual Reports
    tools

    Stock Screener

    Portfolio Tracker

    See More Tools